Children with COVID-19-related inflammatory syndrome fully recover heart function

By American Heart Association News

FatCamera/E+, Getty Images
(FatCamera/E+, Getty Images)

Children who develop COVID-19-related multisystem inflammatory syndrome, also called MIS-C, begin recovering in the first week of hospital discharge and fully recover normal heart function within three months, according to a new study.

The findings, published Wednesday in the Journal of the American Heart Association, suggest children diagnosed with MIS-C can gradually resume playing competitive sports within three months.

"There is limited data at this time about how frequently and how long we should monitor heart function during the recovery state of MIS-C after the child leaves the hospital," study senior author Dr. Anirban Banerjee said in a news release. Banerjee is an attending cardiologist at the Cardiac Center with the Children's Hospital of Philadelphia.

"Given that MIS-C was identified last year as a result of the COVID-19 pandemic, treatment protocols have not yet been standardized, and follow-up care varies greatly, which may lead to confusion and anxiety among families of patients and their care team," Banerjee said. "Our research team hoped to provide some guidance and reduce the ambiguity on optimal care approaches, especially as it relates to sports participation."

MIS-C can appear in children four to six weeks after they've been exposed to COVID-19. It can cause inflammation in the heart, lungs, kidneys and gastrointestinal organs. About 80%-85% of MIS-C cases have involved the heart's left ventricle. The syndrome shares some characteristics with Kawasaki disease, a leading cause of acquired heart disease among young children in the U.S., with an average age of onset of 2. MIS-C, however, is associated with more profound inflammation.

In the new study, researchers detail heart damage and recovery during three to four months of follow-up in 60 children with MIS-C admitted to two Philadelphia hospitals between April 2020 and January 2021. None of the children, who were on average 10 years old, had been diagnosed with COVID-19 before onset of MIS-C symptoms.

Their results were compared with those of 60 children, on average 11.5 years old, who had no known exposure to COVID-19 or symptoms of the virus and whose hearts were structurally normal.

Among those exposed to COVID-19, about 81% lost some ability for the left ventricle to contract during the acute phase of the illness. But that function returned to normal within three to four months.

When first admitted to the hospital, 70% of children showed some signs of heart malfunction. But there were no lasting coronary artery abnormalities and within three months, all scans were normal.

"This study provides additional evidence that myocardial involvement is transient and may not lead to long-term abnormalities" in heart function, Dr. Kevin G. Friedman, a pediatric cardiologist at Boston Children's Hospital, said in the news release. He was not involved in the study.

"Although cardiac involvement in the acute stage of illness is common, it is reassuring that all patients recovered normal cardiac function within about one week," he said. "This data tells us that, fortunately, lasting heart injury is very uncommon in MIS-C."

Editor's note: This story was corrected Jan. 20, 2022. The percent of children showing some signs of heart malfunction when first admitted to the hospital was 70%, not 7%. Because of the rapidly evolving events surrounding the coronavirus, the facts and advice presented in this story may have changed since publication. Visit for the latest coverage, and check with the Centers for Disease Control and Prevention and local health officials for the most recent guidance.

If you have questions or comments about this story, please email [email protected].

American Heart Association News Stories

American Heart Association News covers heart disease, stroke and related health issues. Not all views expressed in American Heart Association News stories reflect the official position of the American Heart Association. Statements, conclusions, accuracy and reliability of studies published in American Heart Association scientific journals or presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect the American Heart Association’s official guidance, policies or positions.

Copyright is owned or held by the American Heart Association, Inc., and all rights are reserved. Permission is granted, at no cost and without need for further request, for individuals, media outlets, and non-commercial education and awareness efforts to link to, quote, excerpt from or reprint these stories in any medium as long as no text is altered and proper attribution is made to American Heart Association News.

Other uses, including educational products or services sold for profit, must comply with the American Heart Association’s Copyright Permission Guidelines. See full terms of use. These stories may not be used to promote or endorse a commercial product or service.

HEALTH CARE DISCLAIMER: This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. If you are in the United States and experiencing a medical emergency, call 911 or call for emergency medical help immediately.